Capecitabine (Capercit) tab 500 mg: Supply issue
There has been a supply issue affecting the 500 mg strength of capecitabine tablets.
Update 28 April 2023
We are confirming a resupply date for Capercit.
Affected product
There is a supply issue affecting of capecitabine 500 mg tablets (Pharmacode 2578123). The 150 mg strength is not currently affected by this supply issue.
Schedule listing for capecitabine(external link)
Resupply date to be confirmed
We are working with the supplier on resupply date for Capercit.
Section 29 alternative product
We listed an alternative brand from 23 February 2023. Stock of Capecitabine-DRLA can be made available by the supplier should the need arise.
Who to contact
If you have any questions about this supply issue, email enquiry@pharmac.govt.nz
Sign up for our email list for regular emails about supply issues and more(external link)